Phase II study of CVP followed by tositumomab and iodine I 131 tositumomab (Bexxar therapeutic regimen) in patients with untreated follicular non-Hodgkin's lymphoma (NHL)

Abstract

Peer reviewed

B. Link, M. S. Kaminiski, M. Coleman and J. P. Leonard

Journal of clinical oncology, Vol.22(14_suppl), pp.6520-6520

07/15/2004

DOI: 10.1200/jco.2004.22.14_suppl.6520

View Online

Title: Subtitle: Phase II study of CVP followed by tositumomab and iodine I 131 tositumomab (Bexxar therapeutic regimen) in patients with untreated follicular non-Hodgkin's lymphoma (NHL)
Creators: B. Link - University of Iowa
M. S. Kaminiski - University of Iowa Hospitals and Clinics
M. Coleman - University of Iowa
J. P. Leonard - University of Iowa
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.22(14_suppl), pp.6520-6520
DOI: 10.1200/jco.2004.22.14_suppl.6520
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 07/15/2004
Academic Unit: Internal Medicine; Radiation Oncology; Hematology, Oncology, and Blood & Marrow Transplantation; Interdisciplinary Studies Program; Orthopedics and Rehabilitation
Record Identifier: 9984305888802771

8 Record Views